All news from Anaesthesiology

Phase 1 Trial of AL001 for Treating Frontotemporal Dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia (FTD).

Benefits of Hot Yoga can To Athlete's Heart, Study Elaborated

When the Canadian Olympic women's field hockey team was preparing for the 2016 games in Rio de Janeiro, a team of researchers from the University of British Columbia and Simon Fraser University had an idea. They wanted to determine if heat stress could enhance the athletes' performance by increasing the volume of plasma in their blood. In order to find out, they asked the athletes to undertake six days of hot yoga immediately before a six-day training camp.